IMU 0.00% 5.5¢ imugene limited

It's cheaper but it'll also be more accessible with more...

  1. 152 Posts.
    lightbulb Created with Sketch. 507
    It's cheaper but it'll also be more accessible with more patients being able to afford treatment and it will also have a greater market share than Herceptin or Keytruda individually, after its paired with both of them (or any other biosimilar) that is. Bring on the licensing deals!
    I don't think Roth would, but I reckon IMU definitely knows how much its costs to manufacture one injection.
    I'm not even sure how Roth calculated 0.71c back in March 2021, but the fact it hasn't increased since yesterday's de-risking leaves me perplexed. smile.png
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.5¢
Change
0.000(0.00%)
Mkt cap ! $404.2M
Open High Low Value Volume
5.6¢ 5.7¢ 5.5¢ $379.9K 6.840M

Buyers (Bids)

No. Vol. Price($)
15 1581916 5.5¢
 

Sellers (Offers)

Price($) Vol. No.
5.6¢ 680013 6
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.